FDA Approves Abecma
FDA Approves Abecma (idecabtagene vicleucel) as the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE) […]
Read moreHome »
FDA Approves Roszet
FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia Morristown, N.J. March 31, 2021 — Althera Pharmaceuticals, a company […]
Read moreMedicamentos ya conocidos, y baratos, podrían ser clave para tratar covid
¿Podría un antidepresivo que se usa desde hace décadas ser un arma secreta contra covid? Algunos científicos creen que sí, después de que dos pequeños […]
Read moreThe Great Undoing: Which of Trump’s Policies Will Biden Reverse?
KHN has put together an interactive tool of significant health policies implemented by the Trump administration using its own authority — executive orders, agency guidance […]
Read morePanadol Flu Strength Day & Night
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PANADOL® FLU STRENGTH DAY & NIGHT CAPLETS Day caplet – Paracetamol 500mg, […]
Read moreAPO-Dipyridamole/Aspirin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO Dipyridamole/Aspirin Modified Release Capsules Modified Release Capsules Contains the active ingredients […]
Read moreAtrovent UDV
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ATROVENT UDVS CMI0119-05 Atrovent 250 µg/1 mL and Atrovent Adult 500 µg/1 […]
Read moreGenRx Alprazolam
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENRX ALPRAZOLAM contains the active ingredient, alprazolam (al-PRAZ-oh-lam) Consumer Medicine Information What […]
Read moreIsotrex
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ISOTREX® GEL Isotretinoin 0.05% w/w Consumer Medicine Information What is in this […]
Read moreTelfast Decongestant
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TELFAST DECONGESTANT® Fexofenadine hydrochloride 60mg / pseudoephedrine hydrochloride 120mg Consumer Medicine Information […]
Read more